| Synta Pharmaceuticals, Inc. | (NQ: SNTA) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(SNTA) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 25, 2013
My notes from the Synta webcast at the Lazard conference on 11/15 are below
For company info featuring ganestespib HSP90 inhibitor can see SNTA research page
For complete...(read more)
A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats
Link
In addition to regulating a number of...(read more)
(Benzinga,
11/4/10)
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results and operational...(read more)
Synta Pharmaceuticals (SNTA) Company Overview
There is no analysis for SNTA yet. But you can go to Wikinvest to help create one!
